

Chris Carlisle
Opus Corporate Finance
William Blythe has pioneered the development and use of inorganic derivatives of elements such as tin, iodine, copper, zinc and tungsten for demanding applications in markets including life sciences, performance coatings, polymers, electronics, catalysts and renewable energy for 180 years.
Opus advised Synthomer Plc on its divestment of William Blythe Ltd to its management team and H2 Equity Partners, for £30m.